Medium materiality5/10
H.C. Wainwright Reiterates Buy Rating on Tvardi Therapeutics Inc (TVRD)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy; PT $9; current price $8.55.
- Wainwright reiterates Buy; TVRD PT $9
Key facts
- 01
Target: $9
- 02
Posted price: $8.55
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Sara Nik
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.